{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:03:27Z","timestamp":1766023407687,"version":"3.48.0"},"reference-count":39,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/cyde1809","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:32Z","timestamp":1756373312000},"page":"6333-6346","source":"Crossref","is-referenced-by-count":0,"title":["YiQiWenShen formula ameliorates myasthenia gravis through T follicular helper cells\/T follicular regulatory cells immune rebalancing"],"prefix":"10.62347","volume":"17","author":[{"given":"Kaihua","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The epidemiology of myasthenia gravis in Korea","volume":"57","author":"Lee","year":"2016","unstructured":"Lee HS, Lee HS, Shin HY, Choi YC and Kim SM. The epidemiology of myasthenia gravis in Korea. Yonsei Med J 2016; 57: 419-25.","journal-title":"Yonsei Med J"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14737159.2021.1927715","article-title":"Improving laboratory diagnostics in myasthenia gravis","volume":"21","author":"Gastaldi","year":"2021","unstructured":"Gastaldi M, Scaranzin S, Businaro P, Mobilia E, Benedetti L, Pesce G and Franciotta D. Improving laboratory diagnostics in myasthenia gravis. Expert Rev Mol Diagn 2021; 21: 579-590.","journal-title":"Expert Rev Mol Diagn"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K and Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med 2021; 10: 2235.","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"839075","DOI":"10.3389\/fimmu.2022.839075","article-title":"A randomized open-labeled trial of methotrexate as a steroid-sparing agent for patients with generalized myasthenia gravis","volume":"13","author":"Di","year":"2022","unstructured":"Di L, Shen F, Wen X, Lu Y, Zhu W, Wang M and Da Y. A randomized open-labeled trial of methotrexate as a steroid-sparing agent for patients with generalized myasthenia gravis. Front Immunol 2022; 13: 839075.","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1039\/D2TB00225F","article-title":"Nano-traditional Chinese medicine: a promising strategy and its recent advances","volume":"10","author":"Wei","year":"2022","unstructured":"Wei D, Yang H, Zhang Y, Zhang X, Wang J, Wu X and Chang J. Nano-traditional Chinese medicine: a promising strategy and its recent advances. J Mater Chem B 2022; 10: 2973-2994.","journal-title":"J Mater Chem B"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1142\/S0192415X22500756","article-title":"Chinese medicine in the treatment of ulcerative colitis: the mechanisms of signaling pathway regulations","volume":"50","author":"Zheng","year":"2022","unstructured":"Zheng S, Xue T, Wang B, Guo H and Liu Q. Chinese medicine in the treatment of ulcerative colitis: the mechanisms of signaling pathway regulations. Am J Chin Med 2022; 50: 1781-1798.","journal-title":"Am J Chin Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.21037\/tp-22-593","article-title":"Single-cell transcriptomics and network pharmacology reveal therapeutic targets of Jianpi Yiqi Bugan Yishen decoction in immune cell subsets of children with myasthenia gravis","volume":"11","author":"Liu","year":"2022","unstructured":"Liu P, Qi G, Gu S, Dong H, Liu C and Yang H. Single-cell transcriptomics and network pharmacology reveal therapeutic targets of Jianpi Yiqi Bugan Yishen decoction in immune cell subsets of children with myasthenia gravis. Transl Pediatr 2022; 11: 1985-2003.","journal-title":"Transl Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Liu M, Wang H, Lv Z, Lu J, Zhang D, Zhu Z, Wu C, Tian Y, Song C, Wu T, Liu L and Chen X. Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022; 101: e32285.","DOI":"10.1097\/MD.0000000000032285"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Jiang L, Xu P, Zhang D, Lu J, Chang T, Zhang Y and Wang J. Treatment of myasthenia gravis with the method of tonifying spleen and replenishing qi in traditional Chinese medicine: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022; 101: e28530.","DOI":"10.1097\/MD.0000000000028530"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2147\/CIA.S414714","article-title":"Gut microbiota and aging: traditional Chinese medicine and modern medicine","volume":"18","author":"Li","year":"2023","unstructured":"Li J, Li D, Chen Y, Chen W, Xu J and Gao L. Gut microbiota and aging: traditional Chinese medicine and modern medicine. Clin Interv Aging 2023; 18: 963-986.","journal-title":"Clin Interv Aging"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa","year":"2021","unstructured":"Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, Yasuda M, Nagane Y and Utsugisawa K. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol 2021; 203: 366-374.","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"641013","DOI":"10.3389\/fimmu.2021.641013","article-title":"Frontiers of autoantibodies in autoimmune disorders: crosstalk between Tfh\/Tfr and regulatory B cells","volume":"12","author":"Ding","year":"2021","unstructured":"Ding T, Su R, Wu R, Xue H, Wang Y, Su R, Gao C, Li X and Wang C. Frontiers of autoantibodies in autoimmune disorders: crosstalk between Tfh\/Tfr and regulatory B cells. Front Immunol 2021; 12: 641013.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"961628","DOI":"10.3389\/fneur.2022.961628","article-title":"Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients","volume":"13","author":"Huang","year":"2022","unstructured":"Huang X, Ran H, Li Y, Ma Q, Ou C, Qiu L, Feng H and Liu W. Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients. Front Neurol 2022; 13: 961628.","journal-title":"Front Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"755356","DOI":"10.3389\/fneur.2021.755356","article-title":"FoxP3(-) Tr1 cell in generalized myasthenia gravis and its relationship with the Anti-AChR antibody and immunomodulatory cytokines","volume":"12","author":"Meng","year":"2021","unstructured":"Meng H, Zheng S, Zhou Q, Gao Y, Ni Y, Liang H and Chen S. FoxP3(-) Tr1 cell in generalized myasthenia gravis and its relationship with the Anti-AChR antibody and immunomodulatory cytokines. Front Neurol 2021; 12: 755356.","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-021-00725-x","article-title":"AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation","volume":"6","author":"Yang","year":"2021","unstructured":"Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, He Z, Zhao M, Lu L, Li F, Long H, Wu H and Lu Q. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther 2021; 6: 341.","journal-title":"Signal Transduct Target Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2017.05.040","article-title":"Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3","volume":"656","author":"Wang","year":"2017","unstructured":"Wang CC, Zhang M, Li H, Li XL, Yue LT, Zhang P, Liu RT, Chen H, Li YB and Duan RS. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3. Neurosci Lett 2017; 656: 169-176.","journal-title":"Neurosci Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"880262","DOI":"10.3389\/fimmu.2022.880262","article-title":"Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation","volume":"13","author":"Yu","year":"2022","unstructured":"Yu Q, Tu H, Yin X, Peng C, Dou C, Yang W, Wu W, Guan X, Li J, Yan H, Zang Y, Jiang H and Xia Q. Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation. Front Immunol 2022; 13: 880262.","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.049","article-title":"Imbalance of circulating CD4(+)CXCR5(+)FOXP3(+) Tfr-like cells and CD4(+)CXCR5(+)FOXP3(-) Tfh-like cells in myasthenia gravis","volume":"630","author":"Wen","year":"2016","unstructured":"Wen Y, Yang B, Lu J, Zhang J, Yang H and Li J. Imbalance of circulating CD4(+)CXCR5(+)FOXP3(+) Tfr-like cells and CD4(+)CXCR5(+)FOXP3(-) Tfh-like cells in myasthenia gravis. Neurosci Lett 2016; 630: 176-182.","journal-title":"Neurosci Lett"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clim.2013.05.009","article-title":"ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh\/Tfr helper cell profiles","volume":"148","author":"Xie","year":"2013","unstructured":"Xie X, Mu L, Yao X, Li N, Sun B, Li Y, Zhan X, Wang X, Kang X, Wang J, Liu Y, Zhang Y, Wang G, Wang D, Liu X, Kong Q and Li H. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh\/Tfr helper cell profiles. Clin Immunol 2013; 148: 162-76.","journal-title":"Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","unstructured":"Baggi F, Annoni A, Ubiali F, Milani M, Longhi R, Scaioli W, Cornelio F, Mantegazza R and Antozzi C. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats. J Immunol 2004; 172: 2697-703.","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"7842296","DOI":"10.1155\/2022\/7842296","article-title":"Endometrial regenerative cell-derived conditioned medium alleviates experimental colitis","volume":"2022","author":"Sun","year":"2022","unstructured":"Sun C, Hao J, Qin H, Zhu Y, Li X, Zhang B, Qin Y, Li G, Wang H and Wang H. Endometrial regenerative cell-derived conditioned medium alleviates experimental colitis. Stem Cells Int 2022; 2022: 7842296.","journal-title":"Stem Cells Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12950-023-00363-w","article-title":"Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response","volume":"20","author":"Sun","year":"2023","unstructured":"Sun J, Chen J, Xie Q, Sun M, Zhang W, Wang H, Liu N, Wang Q and Wang M. Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response. J Inflamm (Lond) 2023; 20: 37.","journal-title":"J Inflamm (Lond)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","unstructured":"Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.","journal-title":"Methods"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08164622.2022.2029683","article-title":"Ocular myasthenia gravis: a review and practical guide for clinicians","volume":"105","author":"Shuey","year":"2022","unstructured":"Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom 2022; 105: 205-213.","journal-title":"Clin Exp Optom"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","article-title":"Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis","volume":"19","author":"Salari","year":"2021","unstructured":"Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, Shohaimi S and Mohammadi M. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med 2021; 19: 516.","journal-title":"J Transl Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","article-title":"Burden of disease in myasthenia gravis: taking the patient’s perspective","volume":"269","author":"Lehnerer","year":"2022","unstructured":"Lehnerer S, Jacobi J, Schilling R, Grittner U, Marbin D, Gerischer L, Stascheit F, Krause M, Hoffmann S and Meisel A. Burden of disease in myasthenia gravis: taking the patient’s perspective. J Neurol 2022; 269: 3050-3063.","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O’Connor KC, Hafler DA, Cudkowicz ME and Barohn RJ; NeuroNEXT NN103 BeatMG Study Team. Phase 2 trial of rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis: the beatMG study. Neurology 2022; 98: e376-89.","DOI":"10.1212\/WNL.0000000000013121"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s00415-022-11458-4","article-title":"Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis","volume":"270","author":"Kwon","year":"2023","unstructured":"Kwon YN, Woodhall M, Sung JJ, Kim KK, Lim YM, Kim H, Kim JE, Baek SH, Kim BJ, Park JS, Seok HY, Kim DS, Kwon O, Park KH, Sohn E, Bae JS, Yoon BN, Kim NH, Ahn SW, Choi K, Oh J, Park HJ, Shin KJ, Lee S, Park J, Kim SH, Seok JI, Bae DW, An JY, Joo IS, Choi SJ, Nam TS, Kim S, Park KJ, Kwon KH, Waters P and Hong YH. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis. J Neurol 2023; 270: 1478-1486.","journal-title":"J Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s13311-022-01223-w","article-title":"Anti-complement agents for autoimmune neurological disease","volume":"19","author":"McCombe","year":"2022","unstructured":"McCombe JA and Pittock SJ. Anti-complement agents for autoimmune neurological disease. Neurotherapeutics 2022; 19: 711-728.","journal-title":"Neurotherapeutics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaccao.2020.10.013","article-title":"Immune checkpoint inhibitor-associated myocarditis with persistent troponin elevation despite abatacept and prolonged immunosuppression","volume":"2","author":"Liu","year":"2020","unstructured":"Liu S, Chan J, Brinc D, Gandhi S, Izenberg A, Delgado D, Abdel-Qadir H, Wintersperger BJ and Thavendiranathan P. Immune checkpoint inhibitor-associated myocarditis with persistent troponin elevation despite abatacept and prolonged immunosuppression. JACC CardioOncol 2020; 2: 800-804.","journal-title":"JACC CardioOncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c(+) B cells","volume":"615","author":"Malle","year":"2023","unstructured":"Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, Richardson A, Barcessat V, Taft J, Bastard P, Samuels J, Mircher C, Rebillat AS, Maillebouis L, Vilaire-Meunier M, Tuballes K, Rosenberg BR, Trachtman R, Casanova JL, Notarangelo LD, Gnjatic S, Bush D and Bogunovic D. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature 2023; 615: 305-314.","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1006136","DOI":"10.3389\/fimmu.2022.1006136","article-title":"Exploration of shared features of B cell receptor and T cell receptor repertoires reveals distinct clonotype clusters","volume":"13","author":"Hong","year":"2022","unstructured":"Hong SB, Shin YW, Hong JB, Lee SK and Han B. Exploration of shared features of B cell receptor and T cell receptor repertoires reveals distinct clonotype clusters. Front Immunol 2022; 13: 1006136.","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"683249","DOI":"10.3389\/fimmu.2021.683249","article-title":"Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands(+) macrophages via activating IL-4\/STAT6\/PD-L2 signaling","volume":"12","author":"Liang","year":"2021","unstructured":"Liang CL, Jiang H, Feng W, Liu H, Han L, Chen Y, Zhang Q, Zheng F, Lu CJ and Dai Z. Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands(+) macrophages via activating IL-4\/STAT6\/PD-L2 signaling. Front Immunol 2021; 12: 683249.","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"637983","DOI":"10.3389\/fimmu.2021.637983","article-title":"Resolvin E1 regulates Th17 function and T cell activation","volume":"12","author":"Oner","year":"2021","unstructured":"Oner F, Alvarez C, Yaghmoor W, Stephens D, Hasturk H, Firatli E and Kantarci A. Resolvin E1 regulates Th17 function and T cell activation. Front Immunol 2021; 12: 637983.","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Asashima H, Axisa PP, Pham THG, Longbrake EE, Ruff WE, Lele N, Cohen I, Raddassi K, Sumida TS and Hafler DA. Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis. J Clin Invest 2022; 132: e156254.","DOI":"10.1172\/JCI156254"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Gonzalez-Figueroa P, Roco JA, Papa I, Nunez Villacis L, Stanley M, Linterman MA, Dent A, Canete PF and Vinuesa CG. Follicular regulatory T cells produce neuritin to regulate B cells. Cell 2021; 184: 1775-1789, e19.","DOI":"10.1016\/j.cell.2021.02.027"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","unstructured":"Pan Z, Zhu T, Liu Y and Zhang N. Role of the CXCL13\/CXCR5 axis in autoimmune diseases. Front Immunol 2022; 13: 850998.","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Hoehn KB, Turner JS, Miller FI, Jiang R, Pybus OG, Ellebedy AH and Kleinstein SH. Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving. Elife 2021; 10: e70873.","DOI":"10.7554\/eLife.70873"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12264-019-00344-1","article-title":"Enhancement of T follicular helper cell-mediated humoral immunity reponses during development of experimental autoimmune myasthenia gravis","volume":"35","author":"Cui","year":"2019","unstructured":"Cui YZ, Qu SY, Chang LL, Zhao JR, Mu L, Sun B, Li HL, Zhang TS, Wang GY and Kong QF. Enhancement of T follicular helper cell-mediated humoral immunity reponses during development of experimental autoimmune myasthenia gravis. Neurosci Bull 2019; 35: 507-518.","journal-title":"Neurosci Bull"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0165767.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:26Z","timestamp":1766023106000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0165767.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/cyde1809","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}